Willingness to pay for antenatal carrier screening for cystic fibrosis

Cam Donaldson* (Corresponding Author), Phil Shackley, Mona Abdalla, Zosia Miedzybrodzka

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

90 Citations (Scopus)


We report on a study of women's willingness to pay (WTP) for a cystic fibrosis carrier test by one or other method of service delivery (disclosure or non-disclosure). The results demonstrate that there was no statistically significant difference in WTP for the methods of testing. Those women who received a negative test result were followed up and asked their WTP for such a result. Values obtained at this stage were 16 per cent higher than those obtained pretest result. Use of prompts, rather than simply asking women to state their WTP, had a statistically significant effect on post-test result values. The opportunity to terminate the pregnancy, if a test proved positive, was important, but was not the only consideration. This demonstrates the importance to women of other benefits of screening.

Original languageEnglish
Pages (from-to)439-452
Number of pages14
JournalHealth Economics
Issue number6
Publication statusPublished - Dec 1995

Bibliographical note

HERU and HSRU are funded by the Chief Scientist Office of the Scottish Office Home and Health Department (SOHHD). However, the opinions expressed in this paper are those of the authors, not SOHHD. The authors are also grateful to the Wellcome Trust for their funding of the CF screening project, to the other contributors to the study from Aberdeen Maternity Hospital, to colleagues in the Health Economists’ Study Group and two anonymous referees for comments on an earlier draft.


  • willingness to pay
  • antenatal screening
  • cystic fibrosis


Dive into the research topics of 'Willingness to pay for antenatal carrier screening for cystic fibrosis'. Together they form a unique fingerprint.

Cite this